$RNA News Article - Avidity Announces Positive AOC 1001 Phase 1/2 MARINA(TM) Data Demonstrating First-Ever Successful Targeted Delivery of RNA to Muscle - Revolutionary Advancement for the Field of RNA Therapeutics
https://marketwirenews.com/news-releases/avid...50663.html